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Objectives
• 1) Assess the effects of injury to the brain in the neurologic injured 
patient and implement a tiered approach to manage severe TBI
• 2) Evaluate TBI patients using multimodality monitoring 
• 3) Apply interventions to manage brain injury & integrate the complex 
multi-system issues and manage these patients using an actual case 
study.
Case DF: Pre-Hospital
•75 year old  male riding bike with helmet on down 
hill went over the handlebars
• VS: BP 166/62 HR 44 R 18 O2 sat 82% on O2
• Awake at seen: GCS 3-5-1 – deteriorating…
• Laceration over left eye / blood coming from ears
Trauma Room 1143- Tier 1 Red
• BP 80/40  HR 50s RR 18 
• Intubated emergently in trauma room
• Neuro
• GCS 1-1-1 
• Right eye 3 mm Left eye 4 mm
• Crepitus over left chest with suspicion of tension pneumothorax right
• Needle thorocostomies
• Bilateral chest tubes
• O2 saturation improves to 100% BP 120/60  
• Heart rate drops to 30s…Patient arrests (Vfib) 10 minutes after arrival
• CPR x 6 minutes
• Defibrillation
• Epinephrine
• Thoracotomy performed - Opened chest 
• Blood products given
• To OR
IntraOp
• Left sided Thoracotomy – cross clamped aorta
• Obvious cardiac contusion
• Multiple lung contusions
• Abdomen opened
• Grade 1 splenic injury
• Mesenteric hematoma
• Flail chest noted with bilateral hemothoraces
• Massive Transfusion
• 6 Packed RBCs, 4 FFP, and Super pack Platelets
• Abdomen left open with wound vac placed
• To CT…
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Admit SICU 300pm
• Decision to induce hypothermia at 36 degrees C x 24 hours due to V Fib arrest
• Concerns about bleeding
• Neurosurgeon decides to hold ICP placement this evening
• Pads placed strategically with open belly
• Pacing wires present
• Bilateral chest tubes to suction
• VS stable
• MAP 80-90  HR 56 Ventilated at 10 breaths/minute
• Neuro
• GCS 1-1-1
• Pupillometer
• Right pupil: NPI 1 CV 0.52 mm/sec
• Left pupil: NPI 0.5 CV 0.09 mm/sec
Severe TBI
• Sum score 3 to 8 &/or motor score < 5
• Brain injury association
• Prolonged unconscious state or coma lasting days, weeks 
or months
• Primary Injury
• Occurs at the time of the event
• Includes EDH, SDH, SAH, Contusions, DAI etc
Secondary Brain Injury
•Secondary Head Injury
• Extracranial causes
• Hypotension
• Hypocapnia and Hypercapnia
• Hypoxia
• Anemia
• Hyperglycemia & Hypoglycemia
• Hyperthermia
TBI Classification by Age Group - Mechanism
http://www.cdc.gov/mmwr/preview/mmwrhtml/figures/s6005a1f5.gif
A bit of Physiology
3 Factors
• CBF
• Phases of CBF after TBI
• Early: Low CBF and
• Days 2-6: Higher CBF –
• Days 7 -14: Low CBF – fall in cytotoxic edema 
• Pressure
• Early to mid week: cytotoxic edema forms during this phase as well as vascular 
engorgement
• Oxygen
• PaO2 is low – vasodilation  
• PaCO2 is low – vasoconstriction   
• PaCO2 is high - vasodilation
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Cerebral Blood Flow
Autoregulation
• Vasomotor control
• Intact: Increase in CPP causes vasoconstriction and 
decrease in ICP
• Vasomotor reactivity failure: Increase in CPP causes 
vasodilation and inc ICP
• Flow metabolism
• ↑ metabolism ↑ CBF
• Metabolic substances
• PaO2
• PaCO2
• pH i.e., acidosis = vasodilatation
Pressure: Intracranial Pressure
• Theories on Brain 
Compartment
• 80% brain
• 10% blood
• 10% CSF
• If one increases the 
other two decrease 
• Compensatory 
mechanisms
SDH
80%
1
0
%
1
0
%
Brain 
moves 
over
CSF shunts 
to spine 
SAS
Venous 
blood to 
heart
Intracranial Pressure
Normal range 
0-15 mm Hg
Abnormal ranges > 20 mm Hg
Cerebral Perfusion 
Pressure
MAP – ICP = CPP
Optimal CPP in TBI
60-80 mm Hg
Intracranial Pressure: It is more than a number…it is 
all about compliance!
P1
P1
P2
P2
P3
P3
Compliant 
Waveform
P1
P2
P3
Non Compliant 
Waveform
P2
P1               P3
Brain Tissue Oxygen  (Pbt02)
• Normal: 20-40 mm Hg
• Risk of death increases
• < 15 mm Hg for 30 minutes
• < 10 mm Hg for 10 minutes
• PbtO2 < 5 mm Hg 
• high mortality
• PbtO2 < 2mm Hg - neuronal death
Influence of Airway/Ventilation Issues
Day 8: Lungs Worsening
ICP is no longer an issue
CO2
42
FIO2 %
80
MAP
71
ICP
14
CPP
56
PbtO2
15.6
Interventions
Increase Dopamine
42 80 76 12 64 18 Chest x-ray reviewed; 
Order to prone patient
43 80 90 17 63 24.5 4 Hours go by…sudden 
change in PbtO2
54 80 101 18 83 12.4 Lung sounds ↓; Supine; 
chest xray- Pneumo
100 Chest tube placed
42 80 94 10 84 34 FIO2 weaned
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Managing Severe TBI
• 2015  ACS TQIP Guidelines
https://www.facs.org/~/media/files/quality%20programs/trauma/tqip/traumati
c%20brain%20injury%20guidelines.ashx
ACS TQIP Guidelines Severe TBI
• Recommendations
• Use GCS to assess Neuro status
• Triage & Transport
• Patients with GCS < 13 and/or combination of GCS < 15 and moderate to severe extra-cranial 
anatomic injuries and AIS > 3 should be transported to highest level trauma center to allow for 
expedient neurosurgical assessment and intervention
• ICP Monitoring
• Important but does not replace neuro exam
• Indicated in patients with 
• GCS <8 (not indicated if no structural injury seen on CT Scan)
• Considered in GCS > 8 with structural brain damage with hig risk for progression (large 
contusions/coagulopathy)
• Indicated in patients requiring urgent surgery for extracranial injuries requiring mechanical ventilation & 
evidence of CT progression of injury
• Preferred method for ICP monitoring is EVD
ACS TQIP Guidelines Severe TBI
• Recommendations: ICP Management
• Global measure
• Additional neuromonitoring (PbtO2, SjO2, Autoregulation, and CBF) 
and assessment of cerebral autoregulation may help to individualize 
treatment
• 3 Tiered approach to ICP Management
• Failure to control ICP/CPP within one tier should prompt rapid 
progression to the next tier’s treatment options
• Repeat CT imaging and neurological exam should be considered to 
rule out the development of surgical lesion and guide management
ACS TQIP Guidelines Severe TBI
• Recommendations: Advanced Neuro Monitoring
• Cerebral Autoregulation may be helpful in identify a more 
individualized approach to treatment
• Impaired cerebral oxygenation can occur in the face of normal ICP and 
CPP
• Cerebrovascular pressure reactivity PRx and CBF monitoring can assess 
autoregulation status which may be helpful in determining patient 
specific CPP and ICP goals
ACS TQIP Guidelines Severe TBI
• Recommendations: Surgical Management
• Large traumatic hematoma should be evacuated before neuro 
deterioration develops irrespective of GCS
• Formal craniotomy is necessary to perform adequate resection
• TBI patients in coma should be taken to the OR immediately if 
large hematoma is identified as cause of coma
• Decompressive craniectomy is effective in controlling ICP but 
uncertainty exists in its potential to improve outcome
Three-Tiered Management of ICP
Tier 1
• Head of Bed elevated 30 degree (reverse Trendelenburg) to improve 
cerebral venous outflow
• Sedation and analgesia using recommended short acting agents
• Propofol, Fentanyl, and Midazolam) in intubated patients
• Ventriculostomy drainage performed intermittently.
• Continuous drainage is not recommended unless additional ICP monitor is 
placed, as when the drain is open, it does not accurately reflect the true ICP
• Repeat CT imaging and neurologic examination should be considered to 
rule out the development of a surgical mass lesion and guide treatment
• IF ICP remains > 20-25 mm Hg, proceed to Tier 2
1/31/2019
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Tier 2
• In patients with a parenchymal ICP monitor, an EVD should be 
considered to allow for intermittent CSF drainage
• Hyperosmolar therapy should be given intermittently as needed for ICP 
elevation and not on a routine schedule
• Mannitol should be administered in intermittent boluses (0.25-1 gm/kg body 
weight) 
• Caution with hypovolemic patient when osmotic diuresis is instituted with mannitol
• Serum sodium and osmolality – assess every 6 hours
• Additional doses should be held if serum osmolality exceeds 320 mOsm/l
• Mannitol should be held if evidence of hypovolemia
Tier 2
• Hyperosmolar therapy should be given intermittently as needed for ICP 
elevation and not on a routine schedule
• Hypertonic saline may be administered in intermittent boluses of 3% sodium 
chloride solution (250 ml over ½ hour) or other concentrations (e.g., 30 cc of 
23.4%)
• Serum sodium and osmolality must be assessed every 6 hours and a
• Additional doses should be held if serum sodium exceeds 160 mEq/L
• Cerebral autoregulation should be assessed 
• If patient is not autoregulating, CPP should be lowered to reduce ICP
• Additional neuromonitoring (e.g., PbtO2, SjvO2, CBF) may help determine 
optimal CPP
Tier 2 Continued
• PaCO2 goal of 30-35 mm Hg should be maintained, as long as brain hypoxia is 
not evident.
• Additional neuromonitoring (e.g. PbtO2, SjbvO2, CBG) may help determine optimal 
PaCO2
• Repeat CT imaging and neurologic examination should be considered to rule 
out development of a surgical mass lesion and guide treatment
• Neuromuscular paralysis achieved with a bolus test dose of a neuromuscular 
blocking agent should be considered if the above measures fail to adequately 
lower ICP and restore CPP
• If there is a positive response, continuous infusion of a NMB should be 
employed (Tier 3)
• If ICP remains > 20-25 mm Hg, proceed to Tier 3
Tier 3
• Decompressive hemi-craniectomy or bilateral craniectomy should only 
be performed if treatments in Tiers 1 and 2 are not sufficient or are 
limited by development of side effects of medical treatment
• NMB paralysis via continuous infusion can be employed if positive 
response to test dose is achieved
• Baribiturate or Propofol coma may be induced
• Hypothermia (< 36 degrees C) is not currently recommended as an initial 
TBI treatment. 
• Hypothermia should be reserved for rescue or salvage therapy after reasonable 
attempts at ICP controls via previous Tier 3 treatments have failed.
ACS TQIP Guidelines Severe TBI
• Nutrition
• Nutrition should begin early as soon as patient is 
hemodynamically stable, within 24-48 hours
• Enteral nutrition is recommended over parenteral nutrition
• Post pyloric feeding methods are preferred
• Tracheostomy
• If LOC remains depressed, TBI patients should undergo 
tracheostomy to facilitate liberation from MV, decreasing 
risk of pneumonia & ventilator induced lung injury
• Relative contraindications: High ICP, Hemodynamic 
instability, & severe respiratory failure
• All TBI patients deemed not likely to improve rapidly should 
be considered within 8 days of injury
ACS TQIP Guidelines Severe TBI
• Venous Thromboembolism prophylaxis
• High rates of DVT (20-30%)
• VTE prophylaxis should be considered iwthing first 72 hours 
following TBI in most patients
• Earlier initiation of pharmacologic prophylaxis (<72 hours) appears 
to be safe in patients at low risk for progression of IC bleeding and 
have stable CT scan
• Prophylactic inferior vena cava filter should be considered in 
patients at high risk for progression of IC hemorrhage and cannot 
receive pharmacologic prophylaxis
1/31/2019
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ACS TQIP Guidelines Severe TBI
Source: ACS TQIP Guidelines 
Page 18
2015  ACS TQIP Guidelines
Pulse Oximetry > 95% ICP 20-25 mm Hg Serum sodium 135-145
PaO2 > 100 mm Hg PtbiO2 > 15 mm Hg INR < 1.4
PaCO2 35-45 mm Hg CPP > 60 mm Hg Platelets > 75,000
SBP > 100 mm Hg Temperature 36-38 C Hemoglobin > 7g/dL
pH 7.35-7.45 Glucose 80-180 meq/L
Goals for Treatment
TQIP Guidelines Focus Severe TBI
• Section on Elderly Patients with TBI
• Often present with GCS 13-15 and appear mild in nature due to brain 
atrophy
• Neuro evaluation more complicated due to dementia, cognitive 
decline, and hearing/visual deficits
• Determine baseline from family
• Anti-coagulants/Anti-platelet medications exacerbate sequalae of TBI
• Reversal is important to remember
• Older age carries higher mortality and worse functional outcome
Management of TBI 
Presence of Anticoagulants/Antiplatelets
• If patient on Anti-
coagulation/anti-
platelet medications 
and have a CT evidence 
of bleeding
• Note the type of 
medication
• Stop drug
• Reversal strategies New: Andexxa
Pathological
Changes
Secondary 
Injury
Coordinated ICU 
Multidisciplinary 
Care
Critical Care Management of 
Severe TBI
Evidence 
Based
Practice
Dynamics of Injury         
&
Monitoring 
Technologies
Severe TBI Patient: GCS 3-8  CT+ Injury
Arrival: Emergency Department Trauma Bay
Assess A-B-C: Oxygenation 
and Ventilation
Airway: Secured with RSI
Breathing: Connect to 
Ventilator
Avoid hyperventilation
Use Capnography to 
monitor ET CO2 (35)
RSI:
Lidocaine 1mg/kg IVP
Etomidate 0.3 mg/kg IVP
Paralytic of Choice
Follow-up: Versed/Fentanyl prn
1/31/2019
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Severe TBI Patient: GCS 3-8  CT+ Injury
Arrival: Emergency Department Trauma Bay
Assess A-B-C: 
Oxygenation and 
Ventilation
Assess Circulation: 
Assess Pulse, ECG and 
BP
IV fluids to maintain 
adequate MAP
Place Foley & OG
Maintain MAP > 80 mm 
Hg with IV NS: 
Assess need for Blood 
Products and/or 
Vasopressors
Assess need for Central 
Line/Arterial Line
Severe TBI Patient: GCS 3-8  CT+ Injury
Arrival: Emergency Department Trauma Bay
Assess Neuro: GCS/Pupils
If S/S Increased ICP
Non-reactive single pupil(s) 
&/or Posturing
Administer 3% Saline 200 ml 
(Preferred) or 
Mannitol 1gm/kg IV (if no 
signs hypotension or bleeding)
Severe  Brain Injury Algorithm
Secondary Survey
Other Interventions as needed
Is patient on any anti-coagulants or 
anti-platelet medications?
Anticoagulation/Anti-platelet Reversal
PCC agents
Platelets/FFP
DDAVP
Radiology: 
CT Scan Non-Contrast/C-Spine
Positive for Bleeding?
PACU:
Hold/Lines Placed if time
Place Central Line/Art line with Flotrac
OR:
Monitors (ICP/PbtO2)/Craniotomy
ED Trauma or SICU RN assist in OR
Severe TBI Patient: GCS 3-8  CT+ Injury
ICU Care: Primary Interventions
Airway/Breathing
Reassess ABG/Baseline Capnography evaluation for accuracy
Maintain PaO2 > 100 mm Hg (Titrate FIO2 based on patient status)
Maintain PaCO2/ETCO2 35 -45 mm Hg: Optimize based on ICP 
and PbtO2
Titrate PaCO2 to balance ICP <20 mm Hg and PbtO2 > 20 mm Hg
Maintain Head of Bed at 30 degrees
Rotate side to side for pulmonary management
Severe TBI Patient: GCS 3-8  CT+ Injury
ICU Care: Primary Interventions
Circulation
Arterial line to Hemodynamic Monitor 
√MAP/SVV/CO/CI
Maintain CPP >60 mm Hg as initial target  
1) Use fluids to maintain SVV < 10-13%  
2) Vasopressors Norepinephrine or Phenylephrine
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Severe TBI Patient: GCS 3-8  CT+ Injury
ICU Care: Tier Approach
ICP Management: Goal ICP < 20 mm Hg and PbtO2 > 20 mm Hg
Tier 1 Interventions: Instituted on admission to ICU
Provide sedation and analgesia
Propofol 10-50 mcg/kg/min & Fentanyl 50-200 mcg/hr
Drain CSF if ventriculostomy in place for ICP> 20 mm Hg
Head of Bed at 30 degrees
Maintain PaCO2 35-45 mm Hg: consider 35 mm Hg if ICP elevated
Keep Temperature 37 – 37.5 degrees C. 
Institute cooling measures x 7 days 
Keep room quiet/lights low
Severe TBI Patient: GCS 3-8  CT+ Injury
ICU Care: Tier Approach
ICP Management: Goal ICP < 20 mm Hg and PbtO2 > 20 mm Hg
Tier 2 Intentions: 
Mannitol 0.25-1.0 gram or Hypertonic Saline 3% 200 ml vs 23% 30 ml over 20-30 minutes 
Consider Propofol 10-50 (up to 100) mcg/kg/min Consider Versed if needed
Consider PaCO2 30-35 mm Hg (monitor PbtO2, SjO2 or CBF if lowering CO2)
Paralytic bolus x 1 – determine ICP response
Consider repeat CT of brain
Tier 3 Interventions:
Paralytic of choice for ventilator control or ICP control (exhaust other interventions first) 
Elective craniectomy per neurosurgery
Mild Hypothermia (33-35) for refractory ICP
Pentobarbital Coma for refractory increased ICP
Note: Use nurse critical thinking algorithm for individualized targeted needs
System Support: 
Monitor Labs/Coags/TEG- Maintain WNL with sodium target  < 160 mg/dL (max)
DVT Prophylaxis: compression boots thigh high and anticoagulation Day 2-4 per MD
OG to suction 
NPO: begin early enteral nutrition Day 1-2 (post pyloric)
Monitor Glucose: 80-180 mg/dL
Foley (temp sensing)
Early Mobility Protocol: 
Cycle Ergometry Begin Day 2-3/ROM
PT/OT/Physiatry consult
ICU Care: Tier Approach
CONCLUSION
PROTOCOLIZE AND INDIVIDUALIZE
Badermk@aol.com
